Nihon Kohden Announces the Close of Its Unique Auction of a New EEG-1200A Diagnostic and Monitoring System
Source Newsroom: American Epilepsy Society (AES)
Newswise — Irvine, Calif., October 31, 2013 — Nihon Kohden America Inc. announces the close of its unique auction of a new EEG-1200A Diagnostic and Monitoring system. The winning bid came from Mary Washington Healthcare. Nihon Kohden will now contribute 100 percent of the auction proceeds to the American Epilepsy Society’s (AES) research and training programs, with a check presentation December 7 at 1:00 p.m. during the society’s annual meeting in Washington, DC.
“Nihon Kohden is proud to again support the American Epilepsy Society in its efforts to further research, education and training in epilepsy. This is our fifth year participating in the equipment auction, and we believe that it benefits both AES and the winning bidder of our EEG equipment,” said Kathy Hart, Vice President of Nihon Kohden America’s Neurology Business group. “AES and Nihon Kohden share a passion for advancing the care and treatment of people with epilepsy, and funds from the equipment auction will help support leading-edge research by the next generation of epilepsy leaders in the U.S.”
“We will be pleased to offer the EEG-1200A as part of our services so our patients may receive state-of-the-art epilepsy screening and monitoring close to home. I’m sure many will enjoy improved quality of life, thanks to more comprehensive diagnosis and treatment,” said Dianne S. McKee, BS, RCP, RRT, Manager of Mary Washington Healthcare’s Sleep and Wake Disorders Centers and Neurodiagnostics.
Nihon Kohden’s support of AES is part of the organization’s $7.5 million “Building for the Future Campaign” to invigorate the society’s educational, research and training efforts. Proceeds from the auction will be designated to support post-doctoral fellowships and early career grants awarded by the Lennox & Lombroso Trust and a clinical research training fellowship awarded by the Susan S. Spencer Fund.
“In a time where researchers are challenged to find creative revenue sources, it is crucial to have generous partners like Nihon Kohden to support vital projects that advance our understanding of epilepsy.” said Jacqueline French, M.D., AES president. “For many years Nihon Kohden has been a leading corporation in its support for epilepsy research, and our hope is that other corporations will follow their lead.”
About Nihon Kohden America
Nihon Kohden America was founded in 1979 as a wholly-owned subsidiary of Nihon Kohden Corporation, Japan (founded in 1951). Nihon Kohden is a market leader in patient monitoring, sleep assessment, neurology and cardiology instrumentation. Its products are distributed to hospitals, physician’s practices, mobile services, and outpatient and surgery centers throughout North America. For more than 60 years, health care providers worldwide have relied on the quality and reliability of Nihon Kohden’s comprehensive and innovative line of neurodiagnostic and monitoring instrumentation to aid in the diagnosis and treatment of patients.
Nihon Kohden’s long legacy in EEG diagnostics and monitoring continues with the EEG- 1200, which combines EEG, long-term epilepsy, cEEG ICU monitoring and sleep testing for the most flexible and comprehensive recording system available today. More information about Nihon Kohden and EEG-1200A technology can be found at www.nkusa.com.
About the American Epilepsy Society (AES)
The American Epilepsy Society, based in West Hartford, Conn., seeks to advance and improve the treatment of epilepsy through the promotion of research and education for healthcare professionals. The 3,000-member medical society for epileptologists and other physicians, allied health care providers and scientists is the nation’s leading medical organization working to eliminate seizures, their fundamental causes and potential neurological effects. The AES annual meeting is the world’s preeminent scientific meeting in epilepsy treatment and research. www.aesnet.org